Failure of ICD Therapy in Lethal Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Caused by the TMEM43 p.Ser358Leu Mutation

HeartRhythm Case Reports - United States
doi 10.1016/j.hrcr.2015.12.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Functional Effects of the TMEM43 Ser358Leu Mutation in the Pathogenesis of Arrhythmogenic Right Ventricular Cardiomyopathy

BMC Medical Genetics
Genetics
2012English

TMEM43-S358L Mutation Enhances NF-κB-TGFβ Signal Cascade in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2018English

Arrhythmogenic Right Ventricular Cardiomyopathy

Heart
Cardiovascular MedicineCardiology
2004English

Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Patients With Tmem43 Gene Mutations: A Comparative Analysis

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Arrhythmogenic Right Ventricular Cardiomyopathy: An Update

Heart
Cardiovascular MedicineCardiology
2009English

Isolated Late Activation Detected by Magnetocardiography Predicts Future Lethal Ventricular Arrhythmic Events in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy

Circulation Journal
MedicineCardiovascular MedicineCardiology
2018English

Echocardiographic Assessment of Arrhythmogenic Right Ventricular Cardiomyopathy

Heart
2001English

CARDIOMYOPATHY: Arrhythmogenic Right Ventricular Cardiomyopathy: Diagnosis, Prognosis, and Treatment

Heart
2000English

Signs of Right Ventricular Myocyte Hypertrophy in Arrhythmogenic Cardiomyopathy

Health and Primary Care
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy